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Androgens mediate a wide range of processes during
embryogenesis and in the adult. In mammals, although
a number of steroids can be shown to exert androgenic
e¡ects using in vitro and in vivo assays, testosterone
and its 5a reduced metabolite, 5a-dihydrotestosterone
(DHT) are considered to represent the principal physio-
logic androgens. Furthermore, although the e¡ects that
androgens exert di¡er widely among di¡erent tissues
and cell types, genetic and biochemical data suggest
that these e¡ects are mediated via the protein products
of a single androgen receptor gene, which is encoded on
the X-chromosome in mammals. Key words: Androgen
receptor, expression, eukaryotes. JID Symposium Proceedings
8:1 ^5, 2003
T
helast decade has witnessed an explosion of informa-
tion regarding the manner in which steroid hor-
mones modulate gene expression. At present, a body
of increasingly detailed information is available con-
cerning the mechanisms by which nuclear receptors,
such as the androgen receptor, regulate the activity of target
genes. Such experiments have identi¢ed a host of molecules cap-
able of modulating the activation or repression of genes by mem-
bers of the nuclear receptor family. In parallel to experiments
focused on the mechanisms by which nuclear receptors regulate
the transcription of responsive genes, other experiments have de-
monstrated the importance of androgen metabolism in speci¢c
cell types.
The results of such investigations provide a framework in
which to view the mechanisms by which genes are regulated dif-
ferentially by androgens in di¡erent tissues and in di¡erent cell
types. The contribution of these in£uences to the regulation of
genes by androgens in normal physiology and in disease states is
in only its earliest stages.
STRUCTURE OF THE ANDROGEN RECEPTOR (AR)
The cloning of the androgen receptor (AR) revealed it to be a
member of a large gene family, the nuclear receptor family. In-
spection of the predicted amino acid sequence of the AR demon-
strates that in common with other members of the nuclear
receptor family, the AR protein sequence contains highly con-
served DNA-binding and ligand-binding domains (Evans, 1988).
These modular domains mediate the recognition of target DNA
sequences by the receptor and the high a⁄nity binding of its an-
drogenic ligands (Fig. 1).
Comparison of the predicted amino acid sequences of the AR
to other members of the NR family demonstrate that the AR is
most closely related to the progesterone and mineralocorticoid
receptors. The androgen receptor is one of the largest members
of the nuclear receptor family, owing to its large amino terminal
segment. This region, which is critical for maximal transcrip-
tional activation of responsive genes, contains a number of re-
peated amino acid motifs. Alteration in the size of the glutamine
repeat element has been linked to the pathogenesis of X-linked
Spinal and Bulbar Muscular Atrophy (SBMA), to an increased
frequency of developing aggressive forms of prostate cancer, and
to a tendency to display oligoazospermia (McPhaul, 2000).
The structure of the AR was determined by the cloning of
cDNAs encoding the receptor protein. Subsequent experiments
identi¢ed a second form of the AR, termed AR-A. On the basis
of experiments using epitope speci¢c antibodies, the AR-A iso-
form is believed to be identical to the long version of the andro-
gen receptor (AR-B) in most of its predicted amino acid
sequence, but lacks the ¢rst 187 amino acids (Zoppi et al, 1993;
Wilson and McPhaul, 1994). Cell transfection assays have demon-
strated measurable di¡erences in the activities of these isoforms
when assayed using di¡erent reporter genes and in di¡erent cell
types (Gao and McPhaul, 1998). Despite striking similarities to
the A- and B- forms of the progesterone receptor, an immuno-
blot survey examining the abundance of the AR-A isoform in
cells and tissues suggest that it is expressed at low levels (Wilson
and McPhaul, 1996). This AR-A isoform is believed to be derived
from internal translational initiation, and not by translation of a
separate AR-A mRNA transcript (Fig 1).
COACTIVATORS
The availability of model reporter genes permitted the functional
characterization of many members of the nuclear receptor family.
The results of transfection assays of receptor function suggested
that intermediary factors played an important role in the normal
function of members of the NR family. Investigations in a num-
ber of laboratories sought to identify these factors using bio-
chemical and genetic methods. The ¢rst of these factors, SRC 1,
was identi¢ed as a protein that interacted with the ligand-binding
domain of the progesterone receptor in a ligand dependent fash-
ion (On ate et al, 1995). In transfection assays, SRC 1was shown to
be capable of augmenting the function of the progesterone recep-
tor when activated by a progesterone receptor agonist. Subse-
quent investigations focused on the mechanism of action of
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other nuclear receptors, particularly the glucocorticoid and estro-
gen receptors, have identi¢ed other related members of this gene
family, now termed the P160 or SRC family of nuclear coacti-
vators (Leo and Chen, 2000). These proteins are believed to
augment the transcriptional activity of nuclear receptors by re-
cruiting enzymatic activities important to the remodeling of
chromatin and by stabilizing the transcriptional preinitiation
complex (McKenna et al, 1999; Zoppi et al, 2002).
A great deal of information has been published relating to the
identi¢cation of proteins that interact with di¡erent members of
the NR family, including the AR. Such studies have demon-
strated that receptor function can be modulated di¡erentially in
di¡erent cellular contexts. Despite the conceptual importance of
such experiments, there is much less information tying these cell-
based results to physiologically relevant processes. The results of
experiments in which individual SRC members have been dis-
rupted have suggested that considerable redundancy exists in the
actions of these proteins. The phenotypes have been relatively
subtle when only individual members are disrupted (Xu et al,
1998; Weiss et al, 1999). Only when multiple members of this
family are disrupted do more severe phenotypes emerge.
COREPRESSORS
Experiments examining the behavior of genes regulated by thyr-
oid and retinoic acid receptors demonstrated that these receptors
exerted two distinct e¡ects on gene activity. In addition to the
stimulation of gene activity that occurred when an agonist ligand
was added, it was noted that expression of the TR (or RAR) in
cells led to a decrease in the basal activity of model responsive
reporter genes. Experiments using fusion proteins containing
portions of the TR and RAR demonstrated that this capacity to
inhibit gene activity could be localized to small segments of these
receptors. Extrapolation of these ¢ndings using genetic and bio-
chemical methods led to the identi¢cation of two proteins,
SMRT (silencing mediator of the retinoid and thyroid hormone
receptors (Chen and Evans, 1995)) and NCoR (nuclear receptor
corepressor (Horlein et al, 1995)) that were responsible for these
inhibitory e¡ects on gene expression. The predicted amino se-
quences of SMRT and NCoR reveal them to be large proteins
(42440 amino acids in length) that contain similar structural
motifs. Subsequent experiments have demonstrated that each
protein is modular and contains regions responsible for mediat-
ing the interaction with nuclear receptors (Hu and Lazar, 1999;
Nagy et al, 1999) and for the assembly of protein complexes that
mediate repression (repression domains).
The mechanisms by which the repressive e¡ects on gene tran-
scription are exerted have been shown to be the result of the re-
cruitment of protein complexes that contain proteins that possess
enzymatic activities, such as histone deacetylase activities
(HDACs) (Perissi et al, 1999; Jepsen et al, 2000). The enzymatic ac-
tivities are believed to facilitate the assembly of compact or inac-
tive chromatin structures. Important for the understanding the
action of antagonists of steroid receptor function, subsequent stu-
dies have demonstrated that SMRT and NCoR are important
modulators of the e¡ects of steroid receptor antagonists (Smith
et al, 1997; Jackson et al, 1997). In these experiments, it has been
shown that corepressor levels in cells can alter the levels of repres-
sion that are observed (Soderstrom et al, 1997).
STABLE COMPLEXES AND NR FUNCTION
The coactivators and corepressors described above have been
identi¢ed on the basis of a⁄nity and interaction with members
of the nuclear receptor family using yeast two-hybrid assays or
physical methods. Using di¡erent methodologies other investiga-
tors have examined the association of members of the nuclear re-
ceptor family with stable complexes present in the nuclear
compartment of mammalian cells. Such studies led to the identi-
¢cation of the TRAP and DRIP complexes that associate with
the thyroid hormone receptor and vitamin D receptor, res-
pectively (Fondell et al, 1996; Rachez et al, 1999). These large,
macromolecular complexes are composed of multiple distinct
polypeptides. Surprisingly, analysis of the composition of these
complexes revealed that in many instances composition was dis-
tinct and did not contain proteins identi¢ed as coactivators or
corepressors in biochemical or yeast screening assays (described
above). Instead, these complexes were found to contain compo-
nents in common with other macromolecular complexes identi-
¢ed as important to the transcription of many the broad classes of
genes in yeast and in mammalian cells (Myers and Kornberg,
2000). These observations suggest that distinct classes of proteins
either participate in the regulation of di¡erent classes of respon-
sive genes or play roles that are temporally distinct. Recent stu-
dies from the laboratory of Myles Brown suggest a complex and
dynamic interaction between these di¡erent groups of proteins
(Shang et al, 2000).
CONFORMATIONAL CHANGES ANDANDROGEN
RECEPTOR FUNCTION
The activity of the AR (and other members of the NR family)
can be regulated by agonist and antagonist ligands. An increasing
body of detailed information is becoming available concerning
how di¡erent classes of ligands have distinct e¡ects on receptor
function. These studies have employed crystallography to de¢ne
the conformational changes that occur as a result of binding of
agonistic or antagonistic ligands to their respective receptors.
They indicate that binding of agonist ligands causes the NR to
assume an activated conformation in which selected surfaces are
exposed, permitting coactivators that modulate gene activation
to bind. By contrast, the binding of antagonist ligands to an
NR causes the receptor to assume a di¡erent conformation in
which the surfaces necessary for coactivator binding are no longer
exposed. It is believed that these conformational changes underlie
the selective recruitment of coactivators or corepressors to ligand-
bound nuclear receptors and contribute to the di¡erential e¡ects
of individual ligands as agonists or antagonists (Brzozowski et al,
1997).
Although this description might suggest that such conforma-
tional changes might be agonist or antagonist in nature, other ex-
periments suggested that these conformations are dynamic and
that multiple di¡erent conformations of a nuclear receptor may
result from the binding of di¡erent ligands (Paige et al, 1999) and
may a¡ect the extent that coactivator and/or corepressors are
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Figure1. Schematic of the structure of the human androgen recep-
tor. The DNA and ligand binding domains of the receptor are shown as
boxes. These critical domains comprise most of the carboxyl terminal por-
tion of the receptor. The amino terminal portion of the AR is required for
full transcriptional activation of responsive genes. Elements containing
stretches of repeated amino acid residues [glutamine (Q), proline (P), and
glycine (G)] are found with in this amino terminal segment. The gluta-
mine and glycine repeats have been demonstrated to be polymorphic in
groups of normal individuals.
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recruited. While additional explanations are certainly possible,
these changes may well contribute to the di¡ering degrees of
agonism or antagonism that are observed in some tissues follow-
ing administration of tissue-selective modulators of steroid recep-
tor functions, such as the selective estrogen receptor modulators
(SERMs).
TESTOSTERONE AND DIHYDROTESTOSTERONE
The importance of 5a-dihydrotestosterone (DHT) formation in
androgen target tissues was ¢rst suggested by independent ex-
periments in the laboratories of Liao andWilson.These investiga-
tors demonstrated that following the administration of
radiolabeled T to animals,Twas converted enzymatically and that
labeled DHT was found bound to the androgen receptor in the
nuclei of cells in androgen target tissues, such as the prostate
(Anderson and Liao, 1968; Bruchovsky andWilson, 1968).
Testosterone and 5a- dihydrotestosterone are the principal an-
drogens in mammals. Although these molecules di¡er only in the
presence of a single double bond between carbons 4 and 5 of the
A ring of the steroid nucleus, physiological and genetic data de-
monstrate that the two hormones are not biologically equivalent
(Fig 2). Patients with genetic 5a-reductase de¢ciency are 46, XY
male pseudohermaphrodites. These individuals demonstrate nor-
mal testicular di¡erentiation and normal levels of circulating tes-
tosterone, yet display defects of male phenotypic development
and display female psychosocial development. In animal experi-
ments, the administration of 5a-reductase inhibitors during em-
bryogenesis impairs or abolishes development of the prostate.
When administered to post pubertal animals, 5a-reductase inhi-
bitors cause a partial involution of the prostate and a reduction in
the levels of expression of androgen-regulated genes.
Attempts to purify 5a-reductase activities were not successful.
Ultimately, the nature of these enzymes awaited studies in which
cDNAs encoding the enzymes were isolated by expression clon-
ing by Andersson and colleagues (Andersson et al, 1989). Using
these techniques, they identi¢ed cDNAs encoding 2 distinct 5a-
reductase isozymes in rat and humans. Subsequent experiments
have demonstrated that this dichotomy is present in many other
mammalian species (Russell andWilson, 1994). Although the role
of the 5a-reductase I enzyme in human physiology remains un-
certain, the 5a-reductase II enzyme is defective in patients with
the 5a-reductase de¢ciency, is crucial for prostate formation and
development, and has been implicated in the pathogenesis of
male pattern baldness (Wilson et al, 1993).
How do the actions of T and DHT di¡er? Any number of
potential explanations might account for the observed
di¡erences in the biological actions of T and DHT. Such
di¡erences might re£ect subtle di¡erences in the conformation
of the AR when complexed to T, compared to DHT. Such
di¡erences might result in the recruitment of di¡erent sets of
coactivators causing the activation of related, overlapping sets of
genes. At the other extreme, these di¡erences might re£ect other
in£uences, such as di¡erential metabolism of the two steroid
hormones.
Investigations of this type have been conducted using whole
cell and broken cell binding assays to examine the manner that
these two androgens are bound by the androgen receptor. These
studies have demonstrated that although T and DHT are both
bound with high a⁄nity by the AR, 5a-dihydrotestosterone is
bound several fold more avidly than is T.When experiments are
performed to examine the stability of preformed complexes of
the AR with T and DHT, AR-DHT complexes are found to
be more stable and dissociate less rapidly (Grino et al, 1990).
Such ¢ndings suggest that di¡erences in the rate of binding
and dissociation of T and DHT are likely to contribute to the
di¡erential regulation of genes by these two androgens.
This model has been examined formally in only a limited
number of models in a limited number of systems. In
transfection experiments, activity of the model androgen-
responsive reporter gene MMTV-CAT was examined following
stimulation with di¡ering concentrations of T and DHT. These
experiments demonstrated that the kinetics of induction of the
reporter gene by T and DHT di¡ered at low concentrations, but
that the maximum activation achieved by both hormones was
identical. Importantly, these experiments were conducted in cells
that were very inactive in the metabolism of androgen (Deslypere
et al, 1992).
Experiments examining these mechanisms in intact animal
models are even more limited. Avila and coworkers prepared
RNA from prostate tissue isolated from three groups of rats:
intact, castrate, and intact animals treated with Finasteride (a 5a-
reductase inhibitor) (Avila et al, 1998). Genes that displayed
patterns of expression suggesting di¡erential regulation under
these three conditions identi¢ed using di¡erential display PCR.
In these experiments, the patterns of gene expression observed
for many genes were felt to be consistent with the ‘‘signal
ampli¢cation’’ model, as was observed for the MMTV-CAT. In a
small proportion of instances, the patterns of gene expression
could not be easily explained on the basis of kinetic di¡erences
of binding of T and DHT to the receptor. These results, instead,
suggested that the changes may instead re£ect the formation of
complexes with distinct conformations (in response to the
binding of T or DHT). Alternatively, these changes might re£ect
the regulation of genes selectively via an indirect mechanism
(e.g., by the formation of estrogen from T, a conversion that is
impossible for DHT).
From the body of available information, a model has emerged
in which the di¡erential e¡ects of T and DHT re£ect (1) the
di¡erent a⁄nity with which T and DHT are bound; and (2) the
measurable di¡erences in the stabilities of the DHT-AR and
O
OH
O
O
OH
OH
O
O
H
O
OH
H
OH
OH
H
Estradiol
Testosterone
5α-
dihydrotestostero
Androstendione
5α-
androstandione
3α, 5α -
androstandiol
Figure 2. Metabolic interconversions of androgens testosterone can
be converted irreversibly (single arrows) to compounds with dis-
tinctly di¡erent biological activities. 5a-reduction of testosterone to
5a-dihydrotestosterone by steroid 5a-reductase increases the potency of
testosterone in many biological systems. Aromatization by the cytochrome
p450 aromatase converts the potent androgen testosterone into the potent
estrogen estradiol. In addition to these irreversible conversions, other rever-
sible pathways (bi-directional arrows) are believed to modulate the levels of
androgen in target cells.
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T-AR complexes. This model presupposes that the concen-
trations of androgen in target cells is limiting in those tissues in
which di¡erential regulation of genes byT and DHT is observed.
While this hypothesis is adequate to explain the patterns of
expression of most androgen-responsive genes, exceptions have
been identi¢ed. In these instances, additional in£uences may be
involved. In some instances such di¡erences may derives from
metabolic conversions that are speci¢c for each ligand (e.g.,
DHT is nonaromatizable). Di¡erential coactivator recruitment
by the T-AR or DHT-AR remains a theoretical possibility
(Figs 2 and 3).
ADDITIONAL MODIFIERS OFANDROGEN ACTION
Much of the preceding has focused on how factors identi¢ed to
regulate the activity of di¡erent NR family members can serve to
modulate the function of the AR. Speci¢cally, this discussion has
focused on the roles played by NR coactivators and repressors,
and the di¡erential action and synthesis of T and DHT in the
modulation of AR-responsive genes.
Many tissues and cell types actively metabolize the physiologic
ligands, T and DHT. One of the most important contributors to
this metabolism is the 17-hydroxysteroid dehydrogenase family
(17-HSD) (Peltoketo et al, 1999).These enzymes catalyze the rever-
sible oxidation-reduction of the hydroxyl group present at the 17
positions of many steroids, including androgens. At least eight
distinct genes have been described. The patterns of expression
vary widely among tissues and even among di¡erent cell types
of an individual tissue. Such di¡erences may serve to modulate
androgen levels ^ and thus androgen action ^ between di¡erent
cell types.
Additional enzymatic conversions may also exert important
in£uences on androgen levels. Selected members of the 3a-HSD
family are also capable of catalyzing the formation or inactivation
of androgens (Penning, 1999). Enzymes of both types have speci-
¢c substrate preferences (e.g., androgens, estrogens) and preferen-
tially catalyze oxidative or reductive reactions (Fig 2). Activities
of this type have been implicated in the development of the male
phenotype in the marsupial (Shaw et al, 2000), and may prove to
play a role in the actions of androgen in mammals as well.
Ligand-independent activation of the progesterone receptor
was ¢rst described in 1991. In these studies, the chicken PRwas
shown to be capable of activation, in the absence of ligand, when
stimulated by cAMP (Power et al, 1991).These observations stimu-
lated investigations in a number of di¡erent systems to determine
whether other nuclear receptors could also be activated in a li-
gand-independent fashion. While a number of studies have re-
ported the ligand-independent activity of androgen receptor
(Ikonen et al, 1994; Nazareth andWeigel, 1996; Darne et al, 1998),
the relevance of these activities to normal androgen physiology
has been demonstrated in only a few model systems (Mani et al,
1994).
CONCLUSION
A number of di¡erent in£uences have been identi¢ed to contri-
bute to the diversity of androgen action that is observed in di¡er-
ent tissues and cell types. The di¡erential expression of
coactivators and corepressors, as well as di¡erences in the rates of
synthesis and inactivation of active androgens have all been
shown to contribute to variations in the actions of androgens in
di¡erent model systems. The present challenge is to take examine
individual systems to assess the contribution of each modi¢er to
the biological system under investigation. Only in this fashion
will it be possible to determine the extent to which these same
factors participate in the pathogenesis of the skin diseases in
which androgens have been implicated.
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